Scholz H
J Am Coll Cardiol. 1984 Aug;4(2):389-97. doi: 10.1016/s0735-1097(84)80231-4.
This report describes various old and new positive inotropic drugs with respect to their mechanisms of action. Drugs with established cardiotonic effects include cardiac glycosides, beta 1-adrenergic agents, glucagon, histamine and the methylxanthines. New agents discussed are prenalterol, beta 2- and alpha-adrenergic drugs, amrinone and sulmazole. Prenalterol is a beta 1-adrenergic agent. Beta 2-adrenergic drugs, amrinone and sulmazole, combine a positive inotropic and a vasodilator effect. The latter resemble theophylline and other methylxanthines in that they appear to act mainly as phosphodiesterase inhibitors with a subsequent increase in cyclic adenosine monophosphate (cAMP). The mechanism of the positive inotropic effect of alpha-adrenergic stimulating agents (for example, phenylephrine) is unknown. It is independent of the cAMP system and is not accompanied by changes in frequency.
本报告描述了各种新旧正性肌力药物的作用机制。具有确定强心作用的药物包括强心苷、β1肾上腺素能药物、胰高血糖素、组胺和甲基黄嘌呤。讨论的新药有普瑞特罗、β2和α肾上腺素能药物、氨力农和舒马唑。普瑞特罗是一种β1肾上腺素能药物。β2肾上腺素能药物、氨力农和舒马唑兼具正性肌力和血管舒张作用。后者与茶碱和其他甲基黄嘌呤类似,因为它们似乎主要作为磷酸二酯酶抑制剂起作用,随后环磷酸腺苷(cAMP)增加。α肾上腺素能刺激剂(如去氧肾上腺素)的正性肌力作用机制尚不清楚。它独立于cAMP系统,且频率无变化。